A New Standard in Drug Testing: Intelligent Bio (NASDAQ: INBS) Delivering Cost-Efficiency, Rapid Results, and Employee Dignity more stocks inside...

As workplaces prioritize safety and efficiency, drug testing remains essential. Traditional methods, however, can be costly, slow, and invasive. Intelligent Bio Solutions Inc. (NASDAQ: INBS) is redefining this process with the INBS Drug Reader, a cutting-edge solution that sets a new standard for workplace drug testing.

Cost-Efficiency and Rapid Results

The INBS Drug Reader offers a cost-effective alternative to traditional drug tests, with each test priced at approximately $20. This affordability allows for more frequent testing, ensuring a safer work environment without the financial burden. Additionally, the device delivers results in just 10 minutes, far quicker than the days it takes for urine or hair tests. This rapid turnaround is crucial in industries like construction and logistics, where immediate decisions are often necessary.

Respect for Employee Dignity

One of the standout features of the INBS Drug Reader is its non-invasive approach. Unlike urine or hair tests, which can be uncomfortable and intrusive, the INBS Drug Reader uses a simple fingerprint scan to detect drug use. This method not only preserves employee dignity but also fosters a more positive workplace culture.

Portability and Tamper-Proof Design

The INBS Drug Reader is portable and tamper-proof, making it ideal for on-site testing and random drug testing policies. Its reliable and immediate results ensure that companies can maintain safety standards without disrupting operations.

By combining affordability, speed, respect for employees, and ease of use, the INBS Drug Reader is setting a new standard for workplace drug testing, helping companies create safer and more productive environments. For more information, visit www.intelligentbiosolutions.com [http://www.intelligentbiosolutions.com/]

Also, here are seven standout undervalued companies, several under $1, demonstrating strong market trends, volume, and heightened awareness:

BranchOut Food Inc. (NASDAQ: BOF) a food technology company, reported a remarkable 640% increase in net revenue for the first half of 2024, Net revenue surged to $2.83 million, signaling robust momentum for the year ahead.

AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) an intellectual property ("IP") focused technology company, announces the closing of the acquisition of Radical Clean Solutions Limited ("RCS") a company which holds worldwide rights in the agriculture space.

CS Diagnostics Group's (OTC: FZRO) CS Protect-Hydrogel, used in radiation therapy to shield healthy tissue, was valued at over 960 million (equivalent to over $1 billion USD). This valuation aligns with a similar product Boston Scientific (NYSE: BSX) acquired for $500 million in 2018. The stock surged 178% in August 2024, rising from $0.32 to $0.89.

Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE): Volume surges as the market responds positively to the new share structure, with shares rebounding from a low of $3 early last week to an intraday high of $10.50 and closing of $8.04 on Thursday August 22, 2024.

Kaival Brands Innovations Group Inc. (NASDAQ: KAVL): The exclusive U.S. distributor of BIDI Registered Stick and global distributor of VEEBA Registered through Philip Morris Products SA (NYSE: PM), trending towards the 52-week low undervalued, a fundamentally sound company worth a look at these levels.

Signal Advance, Inc.'s (OTC: SIGL) Analog Guard Registered could prove a formidable defense against cybercrime and cyberterrorism globally. Yesterday the stock increased 30.57% on 10x average 30-day volume on Tuesday August 27, 2024.

GD Culture Group Limited (NASDAQ: GDC): The stock skyrocketed over 400% this week, climbing from $1.66 to an intraday high of $12 closing at $6.02 on Tuesday August 27, 2024, driven by entering the livestream market through AI Catalysis and news on SyncWaveX.

These companies are currently showing strong market trends, increased trading volumes, and growing investor awareness, making them compelling opportunities for value-focused investors.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=a-new-standard-in-drug-testing-intelligent-bio-nasdaq-inbs-delivering-costefficiency-rapid-results-and-employee-dignity-more-stocks-inside]
Country: United States
Website: http://www.thestreetreports.com



This release was published on openPR.